Fundraise follows foundation model breakthrough in fully de novo antibody design with the Chai-2 series of models Menlo Ventures-led round takes total funding to $100M Former Pfizer Chief Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results